Bottom Line: Beauty and booty
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.TWELVE months ago the Independent recommended that readers should buy shares in Oriflame International, the door-to-door seller of cosmetics.
Good figures yesterday prompted a 6p improvement in the shares to 270p, up 20 per cent since last June, twice the market average.
Most of Oriflame's profit is earnt selling cosmetics via a network of agents in the UK and western Europe.
But the main attraction is Oriflame's ventures into the emerging markets of Eastern Europe and South America.
Political and economic revolutions in these countries have allowed the company to meet pent- up demand for beauty products. Oriflame has been able, at the same time, to widen its distribution network by offering local people the chance to work as sales agents.
Pre-tax profits climbed 17 per cent to pounds 14m and the profit margin widened from 14 to 16 per cent. Emerging markets accounted for 10 per cent of Oriflame's business, but this year it could be a quarter.
Oriflame is unusual in that it is quoted in London, the company is registered in Luxembourg, its management is based in Sweden and most of the manufacturing takes place in Ireland.
Shares are trading on a prospective price/earnings ratio of 10, and the yield is 6 per cent. Continue buying.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments